Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "Hormone Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The market is projected to grow from $17.34 billion in 2022 to $18.48 billion in 2023, at a compound annual growth rate (CAGR) of 6.5%. Furthermore, the market is expected to reach $23.65 billion by 2027, with a CAGR of 6.4%.
Major players in the hormone therapy market include Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi, and AstraZeneca.
Reasons to Purchase:
- Gain a comprehensive global perspective with detailed coverage of 50+ geographies.
- Understand the market's response to COVID-19 and its impact as the virus abates.
- Assess the direct and indirect effects of the Russia-Ukraine war on agriculture, energy, mineral commodity supply, and the market.
- Measure the influence of high global inflation on market growth.
- Develop regional and country-specific strategies based on localized data and analysis.
- Identify investment opportunities in growth segments.
- Outperform competitors using forecast data and insights into market drivers and trends.
- Understand customer dynamics based on the latest market shares.
- Benchmark performance against key competitors.
- Support internal and external presentations with reliable high-quality data and analysis.
Hormone therapy involves altering, suppressing, or increasing certain hormones in the body to treat hormonal imbalances, such as hypothyroidism and others.
The main therapies of hormone therapy include estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, and testosterone replacement. Estrogen hormone replacement therapy involves using estrogen to boost the body's level of this hormone. Various routes of administration, such as oral, parenteral, and others, are used in indications such as menopause, hypothyroidism, growth hormone deficiency, and more, with distribution channels including hospital pharmacies, retail pharmacies, and online pharmacies.
Product innovation is a key trend gaining popularity in the hormone therapy market. Leading companies in the market are focused on launching innovative treatments for hormone imbalance disorders and their symptoms to reduce side effects and introduce treatment options for other symptoms. Such innovations allow these companies to gain a competitive edge in the market.
For instance, in the medical field, new and advanced hormone therapies are continuously being developed to improve treatment efficacy and patient outcomes. This drive for innovation will propel the growth of the hormone therapy market.
North America was the largest region in the hormone therapy market in 2022, with Asia-Pacific expected to experience significant growth. The regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Key countries analyzed in the report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
A surge in the incidences of hormone imbalance disorders is significantly contributing to the growth of the hormone therapy market. Hormone imbalances occur when the body produces either too much or too little of a hormone. Various hormone imbalance disorders include hypothyroidism, hypogonadism, growth hormone deficiency, and others. Hormone therapies, such as estrogen replacement, testosterone replacement, and insulin therapy, are used to treat hormone imbalance disorders.
For instance, according to a report published by London Medical Laboratory in 2022, 19% more people were expected to have significant hormone imbalances in 2022 compared to 2020. This surge in hormone imbalance disorders will drive the demand for hormone therapy.
The hormone therapy market includes revenues earned by entities providing hormone therapies such as insulin therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $18.48 billion |
| Forecasted Market Value (USD) by 2027 | $23.65 billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. Hormone Therapy Market Characteristics
3. Hormone Therapy Market Trends And Strategies
4. Hormone Therapy Market - Macro Economic Scenario
4.1. COVID-19 Impact On Hormone Therapy Market
4.2. Ukraine-Russia War Impact On Hormone Therapy Market
4.3. Impact Of High Inflation On Hormone Therapy Market
5. Hormone Therapy Market Size And Growth
5.1. Global Hormone Therapy Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Hormone Therapy Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Hormone Therapy Market Segmentation
6.1. Global Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Estrogen Hormone Replacement
- Growth Hormone Replacement
- Thyroid Hormone Replacement
- Testosterone Replacement
6.2. Global Hormone Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Oral
- Parenteral
- Other Routes Of Administration
6.3. Global Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Menopause
- Hypothyroidism
- Growth Hormone Deficiency
- Other Indications
6.4. Global Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospitals Pharmacies
- Retail Pharmacies And Stores
- Online Pharmacies
7. Hormone Therapy Market Regional And Country Analysis
7.1. Global Hormone Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Hormone Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/bwg4lp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
